Aguaviva, Jeciel C.

HRN: 14-87-79  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/29/2025
CEFUROXIME 500MG (TAB)
08/29/2025
09/04/2025
PO
500mg
BID
SP Breech Extraction With RMLE
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines